Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Chad Morris to Nicotinic Agonists

This is a "connection" page, showing publications Chad Morris has written about Nicotinic Agonists.

 
Connection Strength
 
 
 
0.854
 
  1. Morris CD, Garver-Apgar CE. Nicotine and Opioids: a Call for Co-treatment as the Standard of Care. J Behav Health Serv Res. 2020 10; 47(4):601-613.
    View in: PubMed
    Score: 0.660
  2. Anthenelli RM, Morris C, Ramey TS, Dubrava SJ, Tsilkos K, Russ C, Yunis C. Effects of varenicline on smoking cessation in adults with stably treated current or past major depression: a randomized trial. Ann Intern Med. 2013 Sep 17; 159(6):390-400.
    View in: PubMed
    Score: 0.101
  3. Williams JM, Anthenelli RM, Morris CD, Treadow J, Thompson JR, Yunis C, George TP. A randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of varenicline for smoking cessation in patients with schizophrenia or schizoaffective disorder. J Clin Psychiatry. 2012 May; 73(5):654-60.
    View in: PubMed
    Score: 0.092
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)